RE: Over sold14 Aug 2020 11:49
what is it people do not like ?
if/when converted @ $6.25
or
to fund the clinical development program of MTX110, our product for DIPG
3,150,000 Ordinary Shares represented by 630,000 ADSs issuable upon exercise of warrants at $6.25 per ADS. These warrants were issued pursuant to a US Registered Direct Offering in October 2019;
9,545,455 Ordinary Shares represented by 1,818,182 ADSs issuable upon exercise of warrants at $2.05 per ADS. These warrants were issued pursuant to a US Registered Direct Offering in May 2020; and
454,549 Ordinary Shares represented by 90,909 ADSs issuable upon exercise of warrants at $2.0625 per ADS. These warrants were also issued pursuant to a US Registered Direct Offering in May 2020.
http://otp.investis.com/clients/us/midatech/SEC/sec-show.aspx?Type=html&FilingId=14331812&CIK=0001643918&Index=10000